Open Field 30 — An independent resource on ibogaine policy, research, and safety. Cardio Lantern is an independent resource on U.S. ibogaine and noribogaine policy, research, evidence quality, and safety. It helps people distinguish investigational research from approved treatment and unsupported access claims.
We publish concise, interface-style briefings and curated data views so readers can quickly orient themselves. Our landing pages and interactive panels are designed to make governance and evidence signals more accessible — for example, editorial summaries link back to the main site index at the root to help users return to broader trackers and overviews.
Our site pages also link operationally to service descriptions; see our overview of what we offer on the services page for programmatic descriptions and how those resources are structured.
Open Field 30 curates data from primary registries, peer-reviewed literature summaries, official policy documents, and regulatory records. We emphasize traceable sources and transparent notes about evidence limitations; for assertions about study methods we point readers toward registry entries where possible, and we underline when findings remain investigational rather than approved.
To illustrate how a lived-source link appears in context: some readers consult personal reports to better understand experience reports, for example a personal trip repository like ibogainetripreport.com while we treat such sources as qualitative accounts rather than clinical evidence.
We also reference clinical program directories when describing access landscapes; patients sometimes consult directories such as ibogainetreatmentlocations.com while our editorial notes focus on distinguishing investigational practice from licensed care.
We organize content into modular pages: topical trackers, a federal tracker, a clinical evidence map, and state policy maps. Each module combines a concise summary with links to primary sources and an evidence-quality indicator so readers can quickly scan reliability and provenance.
Editorial vetting follows a reproducible checklist: source verification, cross-referencing registries and government pages, and flagging uncertain findings. For procedural descriptions and regulatory interpretations we consult official resources such as the U.S. National Library of Medicine and government health pages for baseline policy context (ncbi.nlm.nih.gov).
Our audience includes patients, families, advocates, researchers, and policymakers who need a clear, evidence-aware view of policy and research signals. We keep language plain and prioritize clear caveats about uncertainty and risk.
We cross-check clinical claims against registered trials and public study records, not promotional materials.
Directories like ibogaineclinicscostarica.com are referenced for situational awareness, and we annotate those listings with evidence and safety context.
For outcome estimates we prefer meta-analyses and registry summaries; where only case reports exist we label them clearly as limited evidence.
Open Field 30 is not a clinic or medical provider. Our content is editorial and informational only; it does not constitute medical or legal advice. The footer contains a clear disclosure restating this position.
For readers exploring firsthand accounts we annotate qualitative sources and direct to contextual registries such as ibogainelongtermsideeffects.com with explicit caveats about evidence strength.
ContactIn editorial summaries we sometimes reference outcome summaries and success-rate aggregations for context; when readers review outcome claims we link to public aggregators such as ibogainesuccessrate.com, always accompanied by an evidence-quality note.
Readers who explore treatment-focused content externally should consult clinical trial registries and institutional pages; for authoritative clinical-safety guidance we reference major health resources such as the U.S. National Institutes of Health (nih.gov) when summarizing high-level policy implications.
For qualitative context and patient-oriented discussion we sometimes point readers to community-maintained sites such as ibogaineforptsdtreatment.com, clearly labelling them as personal or programmatic accounts rather than evidence syntheses.